The Cyclin K/Cdk12 complex maintains genomic stability via regulation of expression of DNA damage response genes
Open accessThe DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Abstract
Various cyclin-dependent kinase (Cdk) complexes have been implicated in the regulation of transcription. In this study, we identified a 70-kDa Cyclin K (CycK) that binds Cdk12 and Cdk13 to form two different complexes (CycK/Cdk12 or CycK/Cdk13) in human cells. The CycK/Cdk12 complex regulates phosphorylation of Ser2 in the C-terminal domain of RNA polymerase II and expression of a small subset of human genes, as revealed in expression microarrays. Depletion of CycK/Cdk12 results in decreased expression of predominantly long genes with high numbers of exons. The most prominent group of down-regulated genes are the DNA damage response genes, including the critical regulators of genomic stability: BRCA1 (breast and ovarian cancer type 1 susceptibility protein 1), ATR (ataxia telangiectasia and Rad3-related), FANCI, and FANCD2. We show that CycK/Cdk12, rather than CycK/Cdk13, is necessary for their expression. Nuclear run-on assays and chromatin immunoprecipitations with RNA polymerase II on the BRCA1 and FANCI genes suggest a transcriptional defect in the absence of CycK/Cdk12. Consistent with these findings, cells without CycK/Cdk12 induce spontaneous DNA damage and are sensitive to a variety of DNA damage agents. We conclude that through regulation of expression of DNA damage response genes, CycK/Cdk12 protects cells from genomic instability. The essential role of CycK for organisms in vivo is further supported by the result that genetic inactivation of CycK in mice causes early embryonic lethality.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Micro3 showed similarities to HM_3, HM_4 phenotype but also expressed APOE, apoptosis associated genes XAF1, YWHAB, YWHAG, YWHAE encoding 14–3-3 protein subunits, cell-cycle and cell division control genes CDK12, MIS18BP1, TAF1D, BOD1L1 and CCAR1 [6, 30, 67].”
From Characterisation of premature cell senescence in Alzheimer's disease using single nuclear transcriptomics (2024) · cites this paper as [6]
In the citing paper
“To execute their functions, CDK12 and CDK13 form two separate complexes with CCNK (Blazek et al., 2011; Cheng et al., 2012).”
From Discovery of a molecular glue promoting CDK12-DDB1 interaction to trigger cyclin K degradation (2020) · cites this paper as Blazek et al., 2011
In the citing paper
“CDK12 inactivation is known to cause reduced POLII elongation and premature polyadenylation of select genes enriched in the DNA damage response pathway, resulting in a BRCAness phenotype (Blazek et al., 2011; Dubbury et al., 2018; Johnson et al., 2016).”
From Discovery of a molecular glue promoting CDK12-DDB1 interaction to trigger cyclin K degradation (2020) · cites this paper as Blazek et al., 2011
In the citing paper
“CDK12 forms a complex with CCNK to act as a transcriptional regulator of genes critically involved in DDR pathways (Blazek et al., 2011;Krajewska et al., 2019).”
From Degradation of CCNK/CDK12 is a druggable vulnerability of colorectal cancer (2021) · cites this paper as Blazek et al., 2011
Citations
Cites
Integrated genomic analyses of ovarian carcinoma
Perou, C. M. (2019) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/hvp3-wg08 · Cited by 7,925
The DNA-damage response in human biology and disease
Jackson, S. P., & Bartek, J. (2009) · Nature · doi:10.1038/nature08467 · Cited by 6,092 · cited 4×
“DDR operates through a large network of proteins; however, some proteins lie at the core of DDR mechanisms and regulate responses to several types of lesions (Matsuoka et al. 2007; Jackson and Bartek 2009; Ciccia and Elledge 2010).”
BackgroundInfluentialThe DNA Damage Response: Making It Safe to Play with Knives
Ciccia, A., & Elledge, S. J. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.09.019 · Cited by 4,368
ATM and ATR Substrate Analysis Reveals Extensive Protein Networks Responsive to DNA Damage
Matsuoka, S., Ballif, B. A., Smogorzewska, A., McDonald, E. R., Hurov, K. E., Luo, J., Bakalarski, C. E., Zhao, Z., Solimini, N., Lerenthal, Y., et al. (2007) · Science · doi:10.1126/science.1140321 · Cited by 3,075 · cited 2×
“DDR operates through a large network of proteins; however, some proteins lie at the core of DDR mechanisms and regulate responses to several types of lesions (Matsuoka et al. 2007; Jackson and Bartek 2009; Ciccia and Elledge 2010).”
BackgroundThe DNA Damage Response: Ten Years After
Harper, J. W., & Elledge, S. J. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.11.015 · Cited by 1,705
Bonner, W. M., Redon, C. E., Dickey, J. S., Nakamura, A. J., Sedelnikova, O. A., Solier, S., & Pommier, Y. (2008) · Nature reviews. Cancer · doi:10.1038/nrc2523 · Cited by 1,623 · cited 2×
“DNA double-stranded breaks (DSBs) and DNA interstrand cross-links (ICLs) are among the most severe DNA lesions (Harper and Elledge 2007; Bonner et al. 2008; Jackson and Bartek 2009; Moldovan and D’Andrea 2009).”
Backgroundc-Myc Regulates Transcriptional Pause Release
Rahl, P. B., Lin, C. Y., Seila, A. C., Flynn, R. A., McCuine, S., Burge, C. B., Sharp, P. A., & Young, R. A. (2010) · Cell · doi:10.1016/j.cell.2010.03.030 · Cited by 1,279 · cited 1×
“P-TEFb is considered to be the major Ser2 kinase and was implicated in the regulation of transcriptional elongation of most, if not all, protein-coding genes (Chao et al. 2000; Nechaev and Adelman 2008; Rahl et al. 2010).”
BackgroundControlling the elongation phase of transcription with P-TEFb
Peterlin, B. M., & Price, D. H. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.06.014 · Cited by 1,144 · cited 3×
“Phosphorylation of serine at position 2 (Ser2) is thought to be responsible for productive transcriptional elongation and synthesis of full-length mature mRNA (Peterlin and Price 2006; Bres et al. 2008).”
BackgroundSelf-citationRecruitment of P-TEFb for Stimulation of Transcriptional Elongation by the Bromodomain Protein Brd4
Yang, Z., Yik, J. H. N., Chen, R., He, N., Jang, M. K., Ozato, K., & Zhou, Q. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.06.029 · Cited by 1,138 · cited 13×
“To determine how depletion of P-TEFb and the CycK/Cdk12 complex affects BRCA1 protein levels and global phosphorylation of Ser2, we knocked down both cyclin subunits of P-TEFb and the CycK/Cdk12 complex (Fig.”
BackgroundInfluentialiCLIP reveals the function of hnRNP particles in splicing at individual nucleotide resolution
König, J., Zarnack, K., Rot, G., Curk, T., Kayikci, M., Zupan, B., Turner, D. J., Luscombe, N. M., & Ule, J. (2010) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1838 · Cited by 1,126 · cited 1×
“CEL files were first analyzed with version 3 of ASPIRE software (Konig et al. 2010).”
MethodSelf-citation
Research works printed but not linked: 1
- 10.1038/nature10166 · DOI · Paper page
Cited by
Items 201–300 of 542
The impact of CDK9 on radiosensitivity, DNA damage repair and cell cycling of HNSCC cancer cells
Storch, K., & Cordes, N. (2015) · International Journal of Oncology · doi:10.3892/ijo.2015.3246 · Cited by 39
“One possible explanation is that other CDKs such as CDK12 and CDK13 also regulate, like CDK9, transcription elongation by phosphorylating Rpb1-CTD (32,33).”
BackgroundInfluentialGenomic attributes of homology-directed DNA repair deficiency in metastatic prostate cancer
Sarkar, N. D., Dasgupta, S., Chatterjee, P., Coleman, I. M., Ha, G., Ang, L. S., Kohlbrenner, E. A., Frank, S. B., Nunez, T. A., Salipante, S. J., et al. (2021) · JCI Insight · doi:10.1172/jci.insight.152789 · Cited by 38
Germline and somatic DNA repair gene alterations in prostate cancer
Dall’Era, M., McPherson, J. D., Gao, A. C., White, R. D., Gregg, J. P., & Lara, P. N. (2020) · Cancer · doi:10.1002/cncr.32908 · Cited by 35
“CDK12 is involved with phosphorylating the C-terminal domain of the large subunit of RNA polymerase II and may play a role in DNA repair and genomic stability.(16) CDK12 also may be involved in the expression of other DNA repair genes and CDK12 loss recently was found to be associated with PARP-1 inhibition sensitivit…”
BackgroundCDK12: a potential therapeutic target in cancer
Emadi, F., Teo, T., Rahaman, M. H., & Wang, S. (2020) · Drug Discovery Today · doi:10.1016/j.drudis.2020.09.035 · Cited by 37
Transcriptional cyclin-dependent kinases: Potential drug targets in cancer therapy
Liu, Y., Fu, L., Wu, J., Liu, M., Wang, G., Liu, B., & Zhang, L. (2021) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2021.114056 · Cited by 39
Gene‐specific requirement of RNA polymerase II CTD phosphorylation
Drogat, J., & Hermand, D. (2012) · Molecular Microbiology · doi:10.1111/j.1365-2958.2012.08071.x · Cited by 34
“Similar to the work performed in fission yeast, these studies did not reveal global transcription defects but rather highlighted a specific group of genes implicated in the DNA damage response (Blazek et al., 2011).”
ResultZaborowska, J., Isa, N. F., & Murphy, S. (2016) · BioEssays · doi:10.1002/bies.201670912 · Cited by 39
“clin K associates with CDK12 and CDK13 [28].”
BackgroundBRCA1 or CDK12 loss sensitizes cells to CHK1 inhibitors
Paculová, H., Kramara, J., Šimečková, Š., Fedr, R., Souček, K., Hylse, O., Paruch, K., Svoboda, M., Mistrík, M., & Kohoutek, J. (2017) · Tumor Biology · doi:10.1177/1010428317727479 · Cited by 36
Self-citationTargeting CDK12-mediated transcription regulation in anaplastic thyroid carcinoma
Geng, M., Yang, Y., Cao, X., Dang, L., Zhang, T., & Zhang, L. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.10.052 · Cited by 34
Promoter nucleosome dynamics regulated by signalling through the CTD code
Materne, P., Anandhakumar, J., Migeot, V., Soriano, I., Yague‐Sanz, C., Hidalgo, E., Mignion, C., Quintales, L. A. M., Antequera, F., & Hermand, D. (2015) · eLife · doi:10.7554/elife.09008 · Cited by 32
Reciprocal regulatory links between cotranscriptional splicing and chromatin
de Almeida, S. F., & Carmo‐Fonseca, M. (2014) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2014.03.010 · Cited by 33
“During elongation, CDK12 and Polo-like kinase 3 are also implicated in CTD Ser2 and Thr4 phosphorylation, respectively [21,23,24].”
Ramani, M. K. V., Yang, W., Irani, S., & Zhang, Y. (2021) · Journal of Molecular Biology · doi:10.1016/j.jmb.2021.166912 · Cited by 32
Peng, F., Yang, C., Kong, Y., Huang, X., Chen, Y., Zhou, Y., Xie, X., & Liu, P. (2019) · Current Cancer Drug Targets · doi:10.2174/1568009619666191118113220 · Cited by 32
Curti, L., Rohban, S., Bianchi, N., Croci, O., Andronache, A., Barozzi, S., Mattioli, M., Ricci, F., Pastori, E., Sberna, S., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-51229-5 · Cited by 39
“In addition, CDK12 regulates the expression and processing of genes linked to cell cycle progression and DNA damage signaling and repair 36 – 38 .”
BackgroundmiR-196b target screen reveals mechanisms maintaining leukemia stemness with therapeutic potential
Meyer, S. E., Muench, D. E., Rogers, A. M., Newkold, T. J., Orr, E., O'Brien, E. J., Perentesis, J. P., Doench, J. G., Lal, A., Morris, P. J., et al. (2018) · The Journal of Experimental Medicine · doi:10.1084/jem.20171312 · Cited by 31
“Priority was given to genes with previously validated miR-196b target sites such as HoxA7 (Yekta et al., 2004), genes associated with oncogenic or tumor suppressive pathways such as Cdkn1b (Polyak et al., 1994; Zhang et al., 2013), Braf (Rajagopalan et al., 2002), Cdk12 (Blazek et al., 2011), Phc2 (Isono et al., 2005)…”
Hamilton, M., & Suri, M. (2018) · Advances in genetics · doi:10.1016/bs.adgen.2018.11.001 · Cited by 34
Cyclin-dependent kinases and rare developmental disorders
Colas, P. (2020) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-020-01472-y · Cited by 36
“Whereas CCNK haploinsufficiency causes a number of human anatomical and functional phenotypes that should be potentially detectable in mice, Ccnk pups and adults are perfectly healthy and reproduce well [55].”
BackgroundBlažek, D. (2012) · Cell Cycle · doi:10.4161/cc.11.6.19678 · Cited by 31
Zhang, L., Zhen, Y., Lu, F., Li, Z., Lü, Y., Wang, G., & Ouyang, L. (2023) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2023.115648 · Cited by 33
Ji, J. F., Zhou, C., Wu, J., Cai, Q., Shi, M., Zhang, H., Yu, Y., Zhu, Z., & Zhang, J. (2019) · International Journal of Medical Sciences · doi:10.7150/ijms.34541 · Cited by 31
“DNA damage response genes including BRCA1 (breast and ovarian cancer type 1 susceptibility protein 1), ATR (ataxia telangiectasia and Rad3-related), FANCI (FA complementation group I) and FANCD2 (FA complementation group D2) were its known target genes[12].”
BackgroundYao, G., Tang, J. P., Yang, X., Zhao, Y., Zhou, R., Meng, R., Zhang, S., Dong, X., Zhang, T., Yang, K., et al. (2020) · Theranostics · doi:10.7150/thno.42578 · Cited by 32
“Previous studies have indicated that the Cyclin K/Cdk12 complex may be involved in the regulation of the DNA damage response (DDR) [10-12].”
BackgroundInfluentialThe Genomic Landscape of Prostate Cancer
Spans, L., Clinckemalie, L., Helsen, C., Vanderschueren, D., Boonen, S., Lerut, E., Joniau, S., & Claessens, F. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms140610822 · Cited by 40
“The cyclin-dependent kinase CDK12 protects cells from genomic instability through regulation of expression of DNA damage response genes [68].”
BackgroundKanakkanthara, A., Huntoon, C. J., Hou, X., Zhang, M., Heinzen, E. P., O’Brien, D. R., Oberg, A. L., Weroha, S. J., Kaufmann, S. H., & Karnitz, L. M. (2019) · Nature Communications · doi:10.1038/s41467-019-12610-x · Cited by 32
The role of SETD1A and SETD1B in development and disease
Kranz, A., & Anastassiadis, K. (2020) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2020.194578 · Cited by 35
CDK12 regulates co-transcriptional splicing and RNA turnover in human cells
Magnuson, B., Bedi, K., Narayanan, I. V., Bartkowiak, B., Blinkiewicz, H., Paulsen, M. T., Greenleaf, A. L., & Ljungman, M. E. (2022) · iScience · doi:10.1016/j.isci.2022.105030 · Cited by 35
“Inhibition of CDK12 leads to loss of expression of DNA damage response genes sensitizing cells to DNA-damaging agents and PARP inhibitors (Blazek et al., 2011; Dubbury et al., 2018; Ekumi et al., 2015; Joshi et al., 2014; Krajewska et al., 2019; Wang et al., 2020; Zhang et al., 2016).”
BackgroundInfluentialSynthetic Lethal Targeting of CDK12-Deficient Prostate Cancer with PARP Inhibitors
Chou, J., Robinson, T. M., Egusa, E. A., Lodha, R., Zhang, M., Badura, M. L., Mikayelyan, M., Delavan, H. M., Swinderman, J. T., Wilson, C., et al. (2024) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-23-3785 · Cited by 32
Targeting CDKs in cancer therapy: advances in PROTACs and molecular glues
Marei, H. E. S., Bedair, K., Hasan, A., Al-Mansoori, L., Gaiba, A., Morrione, A., Cenciarelli, C., & Giordano, A. (2025) · npj Precision Oncology · doi:10.1038/s41698-025-00931-8 · Cited by 42
Omar, H. A., & Tolba, M. F. (2019) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2019.01.009 · Cited by 32
Role of Ser7 phosphorylation of the CTD during transcription of snRNA genes
Egloff, S. (2012) · RNA Biology · doi:10.4161/rna.21166 · Cited by 27
Orhan, E., Velázquez, C., Tabet, I., Fenou, L., Rodier, G., Orsetti, B., Jacot, W., Sardet, C., & Theillet, C. G. (2024) · Cancer Letters · doi:10.1016/j.canlet.2024.216820 · Cited by 33
Selective defects in gene expression control genome instability in yeast splicing mutants
Tam, A., Sihota, T. S., Milbury, K. L., Zhang, A., Mathew, V., & Stirling, P. C. (2018) · Molecular Biology of the Cell · doi:10.1091/mbc.e18-07-0439 · Cited by 25
Potential role of Marine Bioactive Compounds in cancer signaling pathways: A review
Manoharan, S., & Perumal, E. (2022) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2022.175330 · Cited by 29
Targeting pre-mRNA splicing in cancers: roles, inhibitors, and therapeutic opportunities
Araki, S., Ohori, M., & Yugami, M. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1152087 · Cited by 34
“Inhibition of CDK12 using siRNAs or small-molecule compounds leads to a predominant decrease in the expression of long genes with high numbers of exons, including breast and ovarian cancer type 1 susceptibility protein 1 (BRCA1), ataxia telangiectasia and Rad3-related (ATR), FA complementation group I (FANCI), and FA…”
BackgroundDual-site molecular glues for enhancing protein-protein interactions of the CDK12-DDB1 complex
Zhang, Z., Li, Y., Yang, J., Li, J., Lin, X., Liu, T., Yang, S., Lin, J., Xue, S., Yu, J., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-50642-0 · Cited by 30
“CDK12 has been linked to DDR genes in triple negative breast cancer(TNBC) 25,44 .”
Sun, R., Wei, T., Ding, D., Zhang, J., Chen, S., He, H. H., Wang, L., & Huang, H. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2205509119 · Cited by 28
“1C), which is consistent with previous reports (29, 35).”
ResultCdk12 Regulates Neurogenesis and Late-Arising Neuronal Migration in the Developing Cerebral Cortex
Chen, H., Juan, H.-C., Wong, Y., Tsai, J., & Fann, M. (2016) · Cerebral Cortex · doi:10.1093/cercor/bhw081 · Cited by 31
“Results from our study on the development of the early embryo showed that loss of Cdk12 reduces expression of Atr, Brca1, Fancd2, and Fanci (Juan et al. 2015).”
BackgroundInfluential435 Candidate biomarkers of PARP inhibitor sensitivity in ovarian cancer beyond the BRCA genes
Hodgson, D., Dougherty, B. A., Lai, Z., Grinsted, L. M., Spencer, S., O’Connor, M. J., Ho, T. W., Robertson, J. D., Lanchbury, J. S. S., Timms, K., et al. (2015) · European Journal of Cancer · doi:10.1016/s0959-8049(16)30269-6 · Cited by 26
Prostate Cancer: A Review of Genetics, Current Biomarkers and Personalised Treatments
Wilson, T. K., & Zishiri, O. T. (2024) · Cancer Reports · doi:10.1002/cnr2.70016 · Cited by 63
“The CDK12 gene encodes the cyclin-dependant kinase (CDK) 12, a 1490 amino acid protein that, with cyclin K, creates a complex to regulate DNA damage repair proteins [125].”
Fan, Y., Wu, Y., Hu, B., Kline, A. D., Zhang, V. W., Liang, D., Sun, Y., Wang, L., Tang, S., Powis, Z., et al. (2018) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2018.07.019 · Cited by 29
Genomic and Phenotypic Biomarkers for Precision Medicine Guidance in Advanced Prostate Cancer
Davoudi, F., Moradi, A., Becker, T. M., Lock, J. G., Abbey, B., Fontanarosa, D., Haworth, A., Clements, J. A., Ecker, R., & Batra, J. (2023) · Current Treatment Options in Oncology · doi:10.1007/s11864-023-01121-z · Cited by 32
“[63, 64].”
van den Akker, W. M. R., Brummelman, I., Martis, L. M., Timmermans, R. N., Pfundt, R., Kleefstra, T., Willemsen, M. H., Gerkes, E. H., Herkert, J. C., van Essen, A. J., et al. (2018) · Clinical Genetics · doi:10.1111/cge.13225 · Cited by 28
“To study the effects of a splice-site variant in intron 7 of CDK13 in mRNA from Individual 10, lymphoblastoid cell lines were generated from peripheral blood cells by Epstein-Barr virus transformation following standard procedures.13 To check for the occurrence of nonsense-mediated decay, mRNA was isolated from cells…”
BackgroundInfluentialChang, Y., Wang, X., Yang, J., Tien, J. C.-Y., Mannan, R., Cruz, G., Zhang, Y., Vo, J. N., Magnuson, B., Mahapatra, S., et al. (2024) · Cell Reports Medicine · doi:10.1016/j.xcrm.2024.101752 · Cited by 34
“12, 15 To determine determine whether To elucidate the impact of CDK12/13 degradation on transient RNA synthesis, nascent transcript sequencing (EU-RNA-seq), a 5-ethynyl uridine (EU)-pulse labeling method, 40 was performed on cells treated with YJ9069.”
Targeting Cyclin-Dependent Kinases in Ovarian Cancer
Zhou, Q. (2017) · Cancer Investigation · doi:10.1080/07357907.2017.1283508 · Cited by 24
“CDK12 plays a role in regulating the transcription of RNA polymerase II genes, including those involved in the response to DNA damage (50).”
BackgroundRouxel, F., Relator, R., Kerkhof, J., McConkey, H., Levy, M. A., Dias, P., Barat‐Houari, M., Bednarek, N., Boute, O., Chatron, N., et al. (2022) · Genetics in Medicine · doi:10.1016/j.gim.2021.12.016 · Cited by 28
“…episignature between CDK13 and CCNK is probably related to these two genes coding for two partner proteins that were shown to interact by forming a complex [8,22] that regulates phosphorylation of Ser2 in the C-terminal domain of RNA polymerase II and expression of a small subset of human genes.”
CDK13, a Kinase Involved in Pre-mRNA Splicing, Is a Component of the Perinucleolar Compartment
Even, Y., Escande, M., Fayet, C., & Genevière, A. (2016) · PLoS ONE · doi:10.1371/journal.pone.0149184 · Cited by 23
“Cyclin L1 α&ß co-precipitate with CDK13 in cell lines over-expressing both proteins whereas the cyclin K subunit has been detected by mass-spectrometry in immunoprecipitated HA-tagged CDK13 complexes [9,14].”
BackgroundInfluentialA combinatorial view of old and new RNA polymerase II modifications
Lyons, D. E., McMahon, S., & Ott, M. (2020) · Transcription · doi:10.1080/21541264.2020.1762468 · Cited by 25
“[128] Blazek D, Kohoutek J, Bartholomeeusen K, et al.”
BackgroundBiswas, R., Gao, S., Cultraro, C. M., Maity, T. K., Venugopalan, A. K., Abdullaev, Z., Shaytan, A. К., Carter, C. A., Thomas, A., Rajan, A., et al. (2016) · Molecular Case Studies · doi:10.1101/mcs.a001263 · Cited by 23
“CDK12 is a transcriptional cyclin-dependent kinase that controls elongation of long complex genes, many of which are involved in DNA damage repair (DDR) (Blazek et al. 2011; Joshi et al. 2014).”
Genomic basis for RNA alterations revealed by whole-genome analyses of 27 cancer typesPreprint
PCAWG Transcriptome Core Group, Calabrese, C., Davidson, N. R., Fonseca, N. A., He, Y., Kahles, A., Lehmann, K.-V., Liu, F., Shiraishi, Y., Soulette, C. M., et al. (2017) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/183889 · Cited by 26
Functional characterization of the human Cdk10/Cyclin Q complex
Düster, R., Ji, Y., Pan, K., Urlaub, H., & Geyer, M. (2022) · Open Biology · doi:10.1098/rsob.210381 · Cited by 22
“The closely related kinase Cdk11 was found to be important for splicing and the expression of histone genes [11,12], whereas Cdk12 plays a selective role in the expression of DNA damage response genes [13,14].”
BackgroundHeterochromatin remodeling by CDK12 contributes to learning in Drosophila
Pan, L., Xie, W., Li, K.-L., Yang, Z., Jiang, X., Zhang, W., Liu, L., Ren, X., He, Z., Wu, J., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1502943112 · Cited by 23
“Because evidence shows that CDK12 affects the expression of long genes in mammals (14), it will be interesting to determine whether heterochromatin enrichment on long genes triggered by CDK12 depletion is conserved in vertebrates and affects important neuronal processes, such as learning or memory.”
BackgroundConnections between 3′ end processing and DNA damage response: Ten years later
Murphy, M. R., & Kleiman, F. E. (2020) · WIREs RNA · doi:10.1002/wrna.1571 · Cited by 17
“In concert with nuclear regulation, control of cytoplasmic deadenylation of ARE-containing mRNA during DDR has also been observed (Blattner et al., 2000; Bollig et al., 2002; Gowrishankar et al., 2005; W. Wang et al., 2000).”
BackgroundKetley, A., Wojciechowska, M., Ghidelli, S., Bamborough, P., Ghosh, T. K., López-Morató, M., Sedehizadeh, S., Malik, N. A., Tang, Z., Powalowska, P. K., et al. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.aaz2415 · Cited by 28
“67% of genes, producing primarily long and complex transcripts, had altered amounts following CDK12 depletion, thereby providing a potential link between CDK12 and transcription of the DM1 expanded repeats (50).”
Background(2025) · doi:10.1016/j.molcel.2025.04.012 · Cited by 21
Guffanti, F., Fratelli, M., Ganzinelli, M., Bolis, M., Ricci, F., Bizzaro, F., Chilà, R., Sina, F. P., Fruscio, R., Lupia, M., et al. (2018) · Oncotarget · doi:10.18632/oncotarget.25185 · Cited by 25
Nováková, M., Hampl, M., Vrábel, D., Procházka, J., Petrezsélyová, S., Procházková, M., Sedláček, R., Kavková, M., Zikmund, T., Kaiser, J., et al. (2019) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2019.00155 · Cited by 21
“In parallel to CDK13, there is CDK12 in mammalian cells able to associate with CycK as well (Blazek et al., 2011; Dai et al., 2012; Liang et al., 2015).”
BackgroundSelf-citationXiang, X., Deng, L., Zhang, J., Zhang, X., Lei, T., Luan, G., Yang, C., Xiao, Z. J., Li, Q., & Li, Q. (2014) · PLoS ONE · doi:10.1371/journal.pone.0101539 · Cited by 21
“Cyclin K was previously thought to associate with CDK9 to regulate gene expression.”
BackgroundInfluentialMutual relationships between transcription and pre‐mRNA processing in the synthesis of mRNA
Lenasi, T., & Barborič, M. (2012) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.1148 · Cited by 26
Zhang, X., Nguyen, K. D. P., Rudnick, P. A., Roper, N., Kawaler, E. A., Maity, T. K., Awasthi, S., Gao, S., Biswas, R., Venugopalan, A. K., et al. (2019) · Molecular & Cellular Proteomics · doi:10.1074/mcp.ra118.001266 · Cited by 20
“CDK12 kinase activity is required for long transcript gene expression such as of the DNA damage response (DDR) genes.”
BackgroundShyamsunder, P., Sridharan, S. P., Madan, V., Dakle, P., Cao, Z., Kanojia, D., Chng, W. J., Ong, S. T., & Koeffler, H. P. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031207 · Cited by 18
“Cells expressing catalytically inactive forms of CDK12 display lowered ability to effectively carry out HR [35].”
BackgroundNi, Z., Ahmed, N., Nabeel‐Shah, S., Guo, X., Pu, S., Song, J., Marcon, E., Burke, G. L., Tong, A. H. Y., Chan, K., et al. (2024) · Nucleic Acids Research · doi:10.1093/nar/gkae240 · Cited by 31
“CCNK is a crucial partner and regulator of CDK12 ( 110 ), and the interaction of the two proteins is vital for the kinase activity responsible for CTD phosphorylation ( 106 ).”
RNA Polymerase II CTD Modifications: How Many Tales From a Single Tail
Napolitano, G., Lania, L., & Majello, B. (2014) · Journal of Cellular Physiology · doi:10.1002/jcp.24483 · Cited by 29
Synthetic lethality: the road to novel therapies for breast cancer
Dhillon, K. K., Bajrami, I., Taniguchi, T., & Lord, C. J. (2016) · Endocrine Related Cancer · doi:10.1530/erc-16-0228 · Cited by 23
Splicing, genome stability and disease: splice like your genome depends on it!
Tam, A., & Stirling, P. C. (2019) · Current Genetics · doi:10.1007/s00294-019-00964-0 · Cited by 19
Proteolysis Targeting Chimeras (PROTACs) in Breast Cancer Therapy
Jin, Y., & Lee, Y. (2024) · ChemMedChem · doi:10.1002/cmdc.202400267 · Cited by 22
Brovkina, O., Shigapova, L. H., Chudakova, D. A., Gordiev, M., Фаридович, Е. Р., Druzhkov, M., Ходырев, Д. С., Shagimardanova, E. I., Nikitin, A. G., & Gusev, O. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00421 · Cited by 21
“Furthermore, cells with CDK12 depletion are more sensitive to DNA damaging agents and exhibit a higher rate of spontaneous DNA damage (29).”
BackgroundThe molecular landscape of pancreatic ductal adenocarcinoma
Sivapalan, L., Kocher, H. M., Ross‐Adams, H., & Chelala, C. (2022) · Pancreatology · doi:10.1016/j.pan.2022.07.010 · Cited by 24
SETD1A regulates transcriptional pause release of heme biosynthesis genes in leukemia
Hoshii, T., Perlee, S. C., Kikuchi, S., Rahmutulla, B., Fukuyo, M., Masuda, T., Ohtsuki, S., Soga, T., Nabet, B., & Kaneda, A. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111727 · Cited by 22
Coming of Age: Targeting Cyclin K in Cancers
Xiao, Y., & Dong, J. (2023) · Cells · doi:10.3390/cells12162044 · Cited by 21
The reversible inhibitor SR-4835 binds Cdk12/cyclin K in a noncanonical G-loop conformation
Schmitz, M., Kaltheuner, I. H., Anand, K., Düster, R., Moecking, J., Monastyrskyi, A., Duckett, D. R., Roush, W. R., & Geyer, M. (2023) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2023.105501 · Cited by 21
“Cdk12 has been shown to affect the transcriptional elongation of a subset of DDR and homologous recombination genes, thereby contributing to genomic stability (20, 24 – 27).”
BackgroundZhang, H., Zhou, Y., Feng, Y., Hou, W., Chen, Y., Xing, Z., Zhang, Y., Wei, Q., Yin, Y., Guo, J., et al. (2024) · Clinical and Translational Medicine · doi:10.1002/ctm2.1678 · Cited by 20
“15,16 Recently, PARPi has been approved to treat BRCA1/2-and ATM-mutated CRPC. 34 However, from clinical data, the response rate of CDK12-mutated prostate cancer patients to PARPi was much lower than that of patients with BRCA2 mutations (Figure 1H).”
BackgroundMethodInfluentialAbril, N., Chicano‐Gálvez, E., Michán, C., Pueyo, C., & López‐Barea, J. (2015) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2015.03.116 · Cited by 23
“Similar protective consequences might have the increase in the levels of CDK12 that stimulate the expression of genomic stability regulators (Blazek et al., 2011) or the decrease of POL2 that favour genomic instability and generate insertions, deletions, altered gene expression, and interindividual variation.”
BackgroundCDK12 Activity-Dependent Phosphorylation Events in Human Cells
Bartkowiak, B., Yan, C. M., Soderblom, E. J., & Greenleaf, A. L. (2019) · Biomolecules · doi:10.3390/biom9100634 · Cited by 18
“CDK12/CyclinK has been shown to phosphorylate the C-terminal repeat domain (CTD) of RPB1, the largest subunit of RNA polymerase II [3,5,6].”
BackgroundInfluentialTissue- and Liquid-Based Biomarkers in Prostate Cancer Precision Medicine
Meehan, J., Gray, M., Martínez-Pérez, C., Kay, C., McLaren, D. B., & Turnbull, A. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11070664 · Cited by 21
“Additional genomic predictive biomarkers for response to immunotherapy have also recently been identified; mutations within cyclin-dependent kinase 12 (CDK12), a tumour suppressor protein with roles connected to genomic stability [348], have also been demonstrated to lead to the creation of neoantigens [349].”
BackgroundLagarde, H., Lallias, D., Patrice, P., Prchal, M., François, Y., D’Ambrosio, J., Segret, E., Perez, A. A., Cachelou, F., Haffray, P., et al. (2023) · Genetics Selection Evolution · doi:10.1186/s12711-023-00811-4 · Cited by 18
“In the fruitfly Drosophila melanogaster, cdk12 is known to be involved in the control of the transcription of a set of genes that have a role in the response to various stress factors: heat shock [105], DNA damage [106], and oxidative stress [107].”
BackgroundPitolli, C., Marini, A., Guerra, M., Pieraccioli, M., Marabitti, V., Palluzzi, F., Giacò, L., Tamburrini, G., Cecconi, F., Nazio, F., et al. (2023) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-023-02790-2 · Cited by 19
“In particular, genetic depletion or pharmacologic inhibition of CDK12 predominantly affected the expression of DNA damage response (DDR) genes [6, 8– 11], thus explaining the BRCA-like phenotype observed in human cancers harbouring mutations in the CDK12 gene [3, 12] and the synergic effect of…”
BackgroundAng, H. X., Sutiman, N., Deng, X., Liu, A., Cerda-Smith, C. G., Hutchinson, H. M., Kim, H., Bartelt, L. C., Chen, Q., Barrera, A., et al. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2221448120 · Cited by 21
“[ 35 S] methionine incorporation was terminated by washing cells twice with 100 µ g/mL cycloheximide (Sigma - Aldrich)in serum - free methionine - free media, incubating for 10 min at 37 °C for the second wash, followed by two washes with 100 µ g/mL cycloheximide in PBS. Cells were then lysed with…”
MethodResultInfluentialFrei, K., Schecher, S., Daher, T., Hörner, N., Richter, J., Hildebrand, U., Schindeldecker, M., Witzel, H. R., Tsaur, I., Porubský, Š., et al. (2023) · International Journal of Cancer · doi:10.1002/ijc.34778 · Cited by 17
“8 Besides inducing a G2/M phase arrest, inhibition of the CycK-CDK12 complex might also result in delayed G1/S phase progression.”
BackgroundMethodInfluentialLu, H., Sun, D., Wang, Z., Cui, H., Min, L., Zhang, H., Zhang, Y., Wu, J., Cai, X., Ding, X., et al. (2025) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.4c01616 · Cited by 18
Żuryń, A., Krajewski, A., Klimaszewska‐Wiśniewska, A., Grzanka, A., & Grzanka, D. (2018) · Oncology Reports · doi:10.3892/or.2018.6919 · Cited by 19
“The loss of function mutations in the CDK12 gene leads to increased cisplatin sensitivity and downregulation of CDK12 induces spontaneous cell death and decreases resistance to different DNA‑damaging agents such as etoposide, mitomycin C and cisplatin (14,54).”
BackgroundChai, Q., Li, S., Collins, M. K., Li, R., Ahmad, I., Johnson, S. F., Frabutt, D. A., Yang, Z., Shen, X., Sun, L., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109514 · Cited by 21
Self-citationCDK13-Mediated Cell Cycle Disorder Promotes Tumorigenesis of High HMGA2 Expression Gastric Cancer
Wu, Z., Wang, M., Li, F., Wang, F., Jia, J., Feng, Z., Huo, X., Yang, J., Wen, J., Sa, R., et al. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.707295 · Cited by 21
“Thus, the function and the mechanism of CDK12 have been comparatively clear; moreover, the inhibitor of CDK12 was invented and has already entered the clinical trials (Blazek et al., 2011; Dubbury et al., 2018; Liang et al., 2020).”
BackgroundA Revision of Herpes Simplex Virus Type 1 Transcription: First, Repress; Then, Express
Dunn, L. E. M., Birkenheuer, C. H., & Baines, J. D. (2024) · Microorganisms · doi:10.3390/microorganisms12020262 · Cited by 18
“The current view is that Ser2 CTD phosphorylation is most important during elongation and termination rather than release from PPP [36,43,57,163–165].”
BackgroundStructure and activation mechanism of the yeast RNA Pol II CTD kinase CTDK-1 complex
Xie, Y., Lord, C. L., Clarke, B. P., Ivey, A. L., Hill, P. S., McDonald, W. H., Wente, S. R., & Ren, Y. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2019163118 · Cited by 14
“Beyond transcription and mRNA biogenesis, proper function of Ctk1 in yeast and CDK12/CDK13 in humans is critical for the regulation of DNA damage-response genes (19, 20).”
BackgroundUehara, T., Takenouchi, T., Kosaki, R., Kurosawa, K., Mizuno, S., & Kosaki, K. (2017) · European Journal of Medical Genetics · doi:10.1016/j.ejmg.2017.12.004 · Cited by 17
Cyclin-dependent kinase 12 (CDK12) in chordoma: prognostic and therapeutic value
Thanindratarn, P., Dean, D. C., Feng, W., Wei, R., Nelson, S. D., Hornicek, F. J., & Duan, Z. (2020) · European Spine Journal · doi:10.1007/s00586-020-06543-z · Cited by 18
Transcription-associated cyclin-dependent kinase 12 (CDK12) as a potential target for cancer therapy
Wu, W., Yu, S., & Yu, X. (2022) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2022.188842 · Cited by 16
Du, X., Qin, W., Yang, C., Dai, L., San, M., Xia, Y., Zhou, S., Wang, M., Wu, S., Zhang, S., et al. (2024) · Genome biology · doi:10.1186/s13059-024-03242-6 · Cited by 21
“S6c), possibly due to the presence of its functionally redundant kinase, CDK13, in cells [66–68].”
BackgroundA curious case of cyclin-dependent kinases in neutrophils
Syahirah, R., Hsu, A. Y., & Deng, Q. (2022) · Journal of Leukocyte Biology · doi:10.1002/jlb.2ru1021-573r · Cited by 15
Guffanti, F., Fruscio, R., Rulli, E., & Damia, G. L. M. (2016) · Scientific Reports · doi:10.1038/srep38142 · Cited by 15
Introduction to Cell Cycle and Its Regulators
Mir, M. A., & Jan, A. (2023) · Springer eBooks · doi:10.1007/978-981-19-8911-7_3 · Cited by 14
Research progress of anticancer drugs targeting CDK12
Yan, Z., Du, Y., Zhang, H., Zheng, Y., Lv, H., Dong, N., & He, F. (2023) · RSC Medicinal Chemistry · doi:10.1039/d3md00004d · Cited by 12
The Toxic Effects of Aflatoxin B1: An Update
Shan, Y. (2020) · IntechOpen eBooks · doi:10.5772/intechopen.88775 · Cited by 19
“CCNK can bind with CDK12 to form the complex CCNK/CDK12 and regulate the expression of several DNA damage response genes and some critical regulators of genomic stability [87].”
BackgroundAndrade, F. D. O., de Assis, S., Lu, J., Fontelles, C. C., Barbisan, L. F., Purgatto, E., Hilakivi‐Clarke, L., & Ong, T. P. (2015) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2015.06.035 · Cited by 15
Non‐Cell Cycle Functions of the CDK Network in Ciliogenesis: Recycling the Cell Cycle Oscillator
Krasińska, L., & Fisher, D. (2018) · BioEssays · doi:10.1002/bies.201800016 · Cited by 12
Molecular Underpinnings Governing Genetic Complexity of ETS-Fusion-Negative Prostate Cancer
Bhatia, V., & Ateeq, B. (2019) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2019.07.001 · Cited by 15
“Previously, CDK12 has been implicated in regulating the expression of several DDR genes [88,89], and was shown to be mutated in advanced CRPC patients [6,11,90].”
BackgroundGhosh, P., Schmitz, M., Pandurangan, T., Tadesse, S., Chan, S. C., Mosior, J., Sun, L., Palve, V. C., Grassie, D., Anand, K., et al. (2025) · RSC Chemical Biology · doi:10.1039/d4cb00190g · Cited by 18
Cross-Talk of Phosphorylation and Prolyl Isomerization of the C-terminal Domain of RNA Polymerase II
Yogesha, S. D., Mayfield, J. E., & Zhang, Y. (2014) · Molecules · doi:10.3390/molecules19021481 · Cited by 14
“Ctk1 binds to Pol II and phosphorylates Ser2 [141,142].”
BackgroundInfluentialLow expression of CDK12 in gastric cancer is correlated with advanced stage and poor outcome
Liu, M., Fan, H., Li, T., Lu, S.-H., Su, Q., & Bi, J. (2020) · Pathology - Research and Practice · doi:10.1016/j.prp.2020.152962 · Cited by 13
Active bacterial modification of the host environment through RNA polymerase II inhibition
Ambite, I., Filenko, N. A., Zaldastanishvili, E., Butler, D. S. C., Tran, T. H., Chaudhuri, A., Esmaeili, P., Ahmadi, S., Paul, S., Wullt, B., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci140333 · Cited by 14
“Finally, CDK9 and CDK12 phosphorylate the CTD of RPB1, activating the RNA polymerase (30, 31).”
Yamazaki, T., Liu, L., & Manley, J. L. (2021) · Transcription · doi:10.1080/21541264.2021.2009421 · Cited by 10
Metadata
- Authors
- Blazek, D., Kohoutek, J., Bartholomeeusen, K., Johansen, E., Hulinkova, P., Luo, Z., Cimermancic, P., Ule, J., & Peterlin, B. M.
- Affiliations
- University of California, San Francisco (US)
- MRC Laboratory of Molecular Biology (GB)
- Venue
- Genes & Development
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2011-10-15
- Volume
- 25
- Issue
- 20
- Pages
- 2158-2172
- ISSN
- 0890-9369 (ISSN-L)
- 1549-5477
- PMC
- PMC3205586
- OpenAlex
- W2123814549
- Cited by
- 522
- References
- 57
- Citations by year
- 2026: 40 · 2025: 36 · 2024: 52 · 2023: 40 · 2022: 35 · 2021: 40 · 2020: 52 · 2019: 45 · 2018: 33 · 2017: 24 · 2016: 29 · 2015: 25 · 2014: 23 · 2013: 24 · 2012: 24
- Type
- posted content
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Genes & Development (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Funders
- Wellcome Trust (089701)
- Grantová Agentura České Republiky
- National Institutes of Health (GM082250)
- National Institute of General Medical Sciences (P50GM082250, IP50 GM082250)
- National Institute of Allergy and Infectious Diseases (R01AI49104, R01AI049104)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Keywords
- cyclin K, CDK12, CDK13, RNA polymerase II Ser2 phosphorylation, transcriptional regulation, DNA damage response genes, genome stability, BRCA1, ATR, FANCI, FANCD2, spontaneous DNA damage, embryonic lethality
- MeSH terms
- Animals, DNA Damage, HeLa Cells, Humans, Phosphorylation, CDC2 Protein Kinase, Cyclins, Mice, Knockout, Gene Expression Regulation, Developmental, Cyclin-Dependent Kinases, Genomic Instability, Cyclin-Dependent Kinase 9, Mice, HEK293 Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.